Clinical Trial Update: Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE [NA]

View source ↗

Summary

A pediatric systemic lupus erythematosus trial evaluating interferon pathway activation in monogenic and nonmonogenic forms is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Systemic Lupus Erythematosus of Childhood | NA | Status: RECRUITING